Oral solid dosage Dosage Forms include tablets, capsules, soft gels, effervescence, gummies, pills and are all examples of small molecules. These oral solid dosage (OSD) Dosage Forms are swallowed through the mouth, dissolved in the digestive system and are passed through first pass metabolism via liver and supplied to the body via bloodstream absorption. Oral solid dosage Dosage Forms are time consuming as compared to parenteral and sublingual’s tablets. Tablets and capsules are the most prevalent OSD Dosage Formulations. The active pharmaceutical ingredient (API), also known as the medication substance, and dry powder components are present in both Dosage Forms. Tablets are compressed and can be coated or uncoated. Coated tablets have an extra layer to create a smooth surface.
Pharmaceutical contract manufacturing is vital in both commercial manufacturing and the late clinical phase of solid dosage medication development and this factor is projected to boost the oral solid dosage pharmaceuticals Dosage Formulation market. Due to high operating and production expenses, big pharma firms possess capacity for biopharmaceutical production, which leads to the privatization of pharmaceutical drug manufacture through contract manufacturing. The market for oral solid dosage pharmaceutical Dosage Formulations is being hampered by growing research on biologic molecules and their supremacy in treating cancer disorders. Furthermore, government investments in biologics research, combined with a surge in biotech start-ups, have harmed oral solid dosage Dosage Forms.
Asia Pacific except Japan (APEJ) is forecast to be the second most profitable market for oral solid dose pharmaceuticals and growing with a CAGR of 8.1% in the forecast time frame. further, Due to expanding generics drug penetration in China and India, APEJ remains the third largest market. A fast surge in new affluent customers in countries like India, China, and Korea is boosting the APEJ market for oral solid dose pharmaceutical Dosage Formulations. The rapidly rising populations of India and China help both international firms and local medicine manufacturers. This group of rich consumers is embracing a luxurious and fast-paced western lifestyle, and as a result, they have begun to suffer from ailments associated with this lifestyle, such as diabetes, cancer, and obesity, for which they seek and can afford innovative drug therapies. In additions, with a market share of 12.5% in 2019, MEA is expected to be the least appealing regional market in terms of revenue.
Despite a huge decline in the sales of Drug Release Mechanisms during the initial phase of pandemic spread and lockdown restrictions all over the region, the market is observed to pick up a quick pace for registering a CAGR of almost more than 6.2%, during the tenure of 2021 – 2027.
The report published by Maximize encompasses the market dynamics, which could affect the market growth of Oral Solid Dosage Pharmaceutical Formulation in the region, the Value – Chain Analysis, and the PORTER’s analysis for the Oral Solid Dosage Pharmaceutical Formulation market at a global level
The study is associated based on major segments and further into sub-segments By Dosage Form (Capsules, Tablets, Powder, Others), Drug Release Mechanism (Ayurvedic, Homeopathic Medicines, Chinese Medicines, Aromatherapy Drug Release Mechanism), Distribution Channels (Hospital Pharmacies, Retail pharmacies, Online Pharmacy, Drug Store), to forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2020, considering 2020 as the base year.
Lastly, the market research report provides a regional comparison and a complete country level analysis for the Drug Release Mechanism trends, along with the major key players- Takeda Pharmaceutical Company Limited, Merck & Co., Inc., d.b.a, Corealis Pharma Inc., Astellas Pharma Inc., CordenPharma International, Bayer AG, AbbVie Inc., Thermo Fisher Scientific Inc. (Patheon N.V.), Lonza, Catalent Inc., Alcami Corporation, Halo Pharmaceutical Inc., CordenPharma International, Arnet Pharmaceuticals, Jubilant Life Sciences, Pfizer Inc., Piramal Enterprises Ltd, Metrics Contract Services, GENVION Corporation, GlaxoSmithKline plc., CMIC HOLDINGS Co., LTD., Tower Laboratories Ltd., PNP Pharmaceuticals Inc., Confab Laboratories Inc., Wockhardt Ltd., Pharma Tech Industries
You can browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Oral Solid Dosage Pharmaceutical Formulation Market.”
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Office no. 4,
Navale IT Zone Phase-2,
Mumbai -Bangalore bypass highway,
Pune- 411041
Maharashtra, India
+91 9607195908